Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search
Page Menu

Active Clinical Studies

IBD & Pregnancy (The MELODY Trial)

 

This study's goal is to determine if manipulation of the mother’s microbiome, through diet, would benefit their baby. The diet aims to promote a healthier immune system during a critical time of immune system development.

Participants 

Pregnant women

Compensation

up to $900

View More

The Oropharyngeal Microbiome and Outcomes in COVID-19

 

The study's goal is to determine if the oropharyngeal microbiome influences the immune system's response to COVID19 and how this could lead to outcomes like need for respiratory support or prolonged COVID19 symptoms. Future work could determine if interventions to change the oropharyngeal microbiome, such as probiotics, could mitigate severe disease manifestations or prevent the development of prolonged symptoms.   

Participants

health care workers who have tested positive for COVID19 regardless of vaccination status

Compensation

$40

View More

Alzheimer’s disease and Immune System Function 

 

Our goal is to compare the microbiome of elders with AD to those without dementia, living in different settings, to determine the role the microbiome plays in cognitive decline while studying local and systemic immune function and brain cellular activity. Understanding how the intestinal microbiome impacts AD development and progression will provide novel therapeutic targets and enable future trials aimed at improving the memory of patients with AD.

Participants

older adults with Alzheimer’s disease

Compensation

up to $200

View More